Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination With or Without Ribavirin in Participants With Chronic Genotype 1 HCV Infection Previously Treated With a Direct Acting Antiviral Regimen
Clinical trial NCT02536313 · COMPLETED
Trial details
- NCT number
- NCT02536313
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-29
- Primary completion
- 2016-03-28
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.